Option update: GlaxoSmithKline volatility flat following earnings warning


GlaxoSmithKline (NYSE: GSK) is recently down $3.75 to $42.13.

GSK reported a declining Q4 pre-tax profit and warned 2008 earnings will be negatively affected by decreasing sales of diabetes drug Avandia, competition from generics and a weak dollar.

GSK overall option implied volatility of 26 is near its 26-week average according to Track Data, suggesting non-directional risk.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Symbol Lookup
IndexesChangePrice
DJIA-130.7012,759.76
NASDAQ-29.932,897.30
S&P 500-13.511,338.44

Last updated: February 10, 2012: 03:43 PM

Hot Stocks

General Electric

18.835-0.295(-1.54)

Alcoa

10.265-0.375(-3.52)

Apple Inc

493.34+0.17(+0.03)

Google Inc 'A'

605.45-6.01(-0.98)

Bank of America

8.055-0.125(-1.53)

Wal-Mart Stores

61.72-0.24(-0.39)

Exxon Mobil Corp

83.51-1.37(-1.61)

Ford

12.425-0.265(-2.09)

Citigroup

32.855-0.805(-2.39)

IBM

191.79-1.34(-0.69)

Yahoo

16.19+0.19(+1.19)

Starbucks

48.705-0.495(-1.01)

Microsoft

30.445-0.325(-1.06)

Home Depot

45.20-0.07(-0.15)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1328906609522 ms.